Huawei and Xiehe jointly developed a patent for non-invasive diabetes testing

Huawei and the Peking Union Medical College Hospital of the Chinese Academy of Medical Sciences published a patent for “Diabetes Risk Detection Methods, Electronic Devices and Systems.”

As per the details, this patent is applied in the field of terminal technology to solve the problem in the existing technology of inaccurate diabetes risk detection results when the PPG signal collection time is short.

The method includes acquiring first data and second data, the first data including a PPG signal acquired by a photoplethysmography PPG sensor. The second data includes one or more of the following: diet data, exercise data, physical symptom data, drug usage data, sleep data, and emotion data.

The diabetes risk detection result is determined based on the first data and the second data, and the detection result is finally output to prompt the user of the health status.  The patent summary diagram shows that the patent not only supports the non-invasive detection of diabetes.